Dapagliflozin Approval UK (Forxiga) - MHRA Status
Forxiga is MHRA-approved in the UK for type 2 diabetes, heart failure with reduced ejection fraction, and chronic kidney disease. See approval details and dates.
Dapagliflozin
89 source-based articles maintained by the HealthRX.com Editorial Team.
89articles
7topic areas covered
May 25, 2026latest review
Dapagliflozin library
Showing 89 of 89 clinical reviews.
Dapagliflozin First Approved: FDA Timeline Since 2014
Dapagliflozin (Farxiga) first won FDA approval on January 8, 2014 for type 2 diabetes, then expanded to heart failure in 2020 and chronic kidney disease in 2021.
Dapagliflozin in Elderly Patients: No Dose Adjustment
No age-based dose change needed: standard dose is 10 mg for HF/CKD, 5-10 mg for T2D. Monitor renal function, volume status, and fall risk in adults 65+.
Dapagliflozin in Pregnancy: Risks and Safer Alternatives
Dapagliflozin is contraindicated in the 2nd and 3rd trimesters due to fetal renal toxicity; insulin is the preferred option for diabetes in pregnancy.
Dapagliflozin Metabolism: UGT1A9 and CYP Role in Farxiga Label
Dapagliflozin is metabolized mainly by UGT1A9, not CYP enzymes; variants can shift drug exposure 15-55%, though no FDA dosing change is required.
Dapagliflozin Patent Expiry Date and Generic Timeline
Farxiga's core patent expires October 2026, with pediatric exclusivity possibly pushing generics to April 2027. Four ANDA filers have already challenged it.
Dapagliflozin Pediatric Use: Not Approved Under Age 12
Dapagliflozin (Farxiga) has no FDA approval for children under 12; no trials tested it below age 18. See how it compares to Jardiance's pediatric approval.
Dapagliflozin Prescribing Info: Dosing for Ages 50-64
Dapagliflozin dosing for adults 50-64: 10 mg once daily for T2D, HFrEF, HFpEF and CKD; no age-based adjustment, but check eGFR before and during treatment.
Dapagliflozin Renal Dose: eGFR Thresholds Explained
Dapagliflozin stays at 10 mg daily regardless of kidney function. Starts at eGFR ≥25; continue until dialysis or transplant. DAPA-CKD data included.
Does Aetna (CVS Health) Cover Farxiga (Dapagliflozin)?
A complete guide to Aetna (CVS Health) Farxiga coverage, prior authorization criteria, step therapy requirements, formulary tier placement, and how to appeal a denial in 2024.
Does Anthem (Elevance Health) Cover Farxiga (Dapagliflozin)?
A detailed guide to Anthem (Elevance Health) Farxiga coverage, including formulary tier, prior authorization criteria, step therapy requirements, appeal strategies, and cost-saving options for dapagliflozin.
Does Blue Cross Blue Shield (Federated) Cover Farxiga (Dapagliflozin)?
A clinical and insurance guide to Farxiga coverage under Blue Cross Blue Shield Federated plans, including prior authorization criteria, step therapy requirements, formulary tiers, appeal strategies, and cost-reduction options.
Does Cigna Cover Farxiga (Dapagliflozin)? Prior Authorization, Formulary Tier, and Appeal Steps
Cigna covers Farxiga (dapagliflozin) for type 2 diabetes, heart failure, and CKD with prior authorization. Learn the formulary tier, step therapy rules, PA criteria, and how to appeal a denial.
Does Farxiga Cause Bladder Cancer? FDA Findings
Early bladder cancer concerns with Farxiga were resolved after review; FDA signals now focus on DKA, serious UTIs and Fournier gangrene.
Does Humana Cover Farxiga (Dapagliflozin)? Coverage, Prior Auth, and Appeals
A detailed guide to Humana's formulary status for Farxiga (dapagliflozin), prior-authorization criteria, step-therapy requirements, appeal strategies, and cost-reduction options for 2024 to 2025.
Does Kaiser Permanente Cover Farxiga (Dapagliflozin)?
A detailed guide to Kaiser Permanente formulary status, prior authorization criteria, step therapy requirements, and appeal strategies for Farxiga (dapagliflozin) covering type 2 diabetes, heart failure, and CKD indications.
Does Medicare Advantage Cover Farxiga (Dapagliflozin)?
Medicare Advantage plans generally cover Farxiga for type 2 diabetes, heart failure, and CKD under Part D formularies. Learn about prior authorization, step therapy, tier placement, appeals, and out-of-pocket costs.
Does State Medicaid Cover Farxiga (Dapagliflozin)?
A state-by-state guide to Medicaid coverage of Farxiga (dapagliflozin) for type 2 diabetes, heart failure, and CKD, including prior authorization criteria, step therapy requirements, formulary tiers, and how to appeal a denial.
Does TRICARE Cover Farxiga (Dapagliflozin)? Coverage, Prior Auth, and Appeals Explained
A complete guide to TRICARE coverage of Farxiga (dapagliflozin) for type 2 diabetes, heart failure, and CKD, including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Does UnitedHealthcare Cover Farxiga (Dapagliflozin)?
A complete guide to UnitedHealthcare coverage for Farxiga (dapagliflozin), including formulary tier, prior authorization criteria, step therapy requirements, appeals, and cost-saving options for type 2 diabetes, heart failure, and CKD.
Farxiga (Dapagliflozin) Adolescent Dosing: Ages 12 to 17
Evidence-based guide to dapagliflozin (Farxiga) dosing in adolescents aged 12-17, covering FDA-approved indications, off-label pediatric use, clinical trial data, and monitoring protocols.
Farxiga (Dapagliflozin) Adult Dosing for Ages 30 to 49: Complete Clinical Guide
Evidence-based dapagliflozin dosing guide for adults aged 30, 49 covering type 2 diabetes, heart failure, and CKD indications with trial data, renal adjustments, and practical clinical advice.
Farxiga (Dapagliflozin) Complete Drug-Drug Interaction Profile
Dapagliflozin is cleared mainly by UGT1A9 glucuronidation to an inactive 3-O-glucuronide. CYP450 does little, so CYP-based drug interactions stay limited.
Farxiga (Dapagliflozin) Cost in Florida: Prices, Insurance, and Savings in 2026
Current Farxiga (dapagliflozin) pricing in Florida for 2026, including cash-pay costs, Medicaid coverage status, insurance options, telehealth access, and AstraZeneca savings programs.
Farxiga (Dapagliflozin) Cost in Georgia: 2026 Prices, Insurance, and Savings Options
Complete 2026 guide to Farxiga (dapagliflozin) pricing in Georgia, including Medicaid coverage rules, insurance options, compounded alternatives, AstraZeneca savings cards, and telehealth access.
Farxiga (Dapagliflozin) Cost in Illinois: 2026 Pricing, Insurance, and Savings Guide
Current Farxiga pricing in Illinois for 2026, including cash-pay costs, Medicaid coverage with prior authorization, AstraZeneca savings cards, and compounded dapagliflozin options through 503A pharmacies.
Farxiga (Dapagliflozin) Cost in Massachusetts: Pricing, Insurance, and Savings in 2026
Find out what Farxiga (dapagliflozin) costs in Massachusetts in 2026, including retail pricing, Medicaid coverage, insurance options, manufacturer savings cards, and compounded alternatives.
Farxiga (Dapagliflozin) Cost in Michigan: Prices, Insurance, and Savings for 2026
Find out what Farxiga (dapagliflozin) costs in Michigan in 2026, including cash prices, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
Farxiga (Dapagliflozin) Cost in Minnesota: 2026 Prices, Insurance, and Savings
Current Farxiga pricing in Minnesota for 2026, including cash-pay costs, Minnesota Medicaid coverage, insurance options, the AstraZeneca savings card, and compounded dapagliflozin availability through 503A pharmacies.
Farxiga (Dapagliflozin) Cost in Missouri: Prices, Insurance, and Savings in 2026
What determines what Missouri patients actually pay for Farxiga (dapagliflozin): FDA-approved indications, Missouri Medicaid coverage rules, commercial insurance tiering, manufacturer savings programs, and compounded alternatives, with a checklist for separating stable facts from ones that change monthly.
Farxiga (Dapagliflozin) Cost in Montana 2026: Pricing, Insurance, and Savings Options
A guide to what actually determines Farxiga (dapagliflozin) costs in Montana, what is confirmed by FDA labeling versus what changes month to month with insurers and pharmacies, and how to verify current pricing before you rely on any number.
Farxiga (Dapagliflozin) Cost in New York: Prices, Insurance, and Savings in 2026
Current Farxiga (dapagliflozin) pricing in New York for 2026, including cash-pay costs, Medicaid coverage, insurance options, manufacturer savings cards, and compounded alternatives.
Farxiga (Dapagliflozin) Cost in North Carolina: Prices, Insurance, and Savings in 2026
Farxiga costs about $620/month at North Carolina retail pharmacies in 2026. Learn about NC Medicaid coverage, insurance options, the AstraZeneca savings card, compounded dapagliflozin, and telehealth access.
Farxiga (Dapagliflozin) Cost in Texas: Prices, Insurance, and Savings in 2026
What Farxiga costs in Texas in 2026, including cash prices, Medicaid coverage, insurance options, manufacturer savings cards, and compounded dapagliflozin availability.
Farxiga (Dapagliflozin) Cost in Utah: Prices, Insurance, and Savings for 2026
Current Farxiga pricing in Utah for 2026, including retail cost, Utah Medicaid coverage status, insurance options, AstraZeneca savings cards, compounded dapagliflozin access, and telehealth availability.
Farxiga (Dapagliflozin) Cost in Virginia: 2026 Pricing, Insurance, and Savings Guide
What is actually known about Farxiga (dapagliflozin) pricing, insurance coverage, and savings options for Virginia patients in 2026, including which claims are stable federal facts and which are date-sensitive and require direct verification.
Farxiga (Dapagliflozin) Cost in Wyoming: 2026 Prices, Insurance, and Savings Options
Farxiga costs about $620/month at Wyoming retail pharmacies in 2026. Learn about Wyoming Medicaid coverage, insurance options, the AstraZeneca savings card, and compounded dapagliflozin availability.
Farxiga (Dapagliflozin) Dosing in Hepatic Impairment
Evidence-based guide to dapagliflozin dosing in patients with liver disease, including mild, moderate, and severe hepatic impairment. FDA label data, pharmacokinetic studies, and clinical trial evidence reviewed.
Farxiga (Dapagliflozin) Food & Supplement Interactions
Evidence-based guide to dapagliflozin food and supplement interactions, including alcohol, high-sodium diets, diuretic herbs, and common supplements that affect SGLT2 inhibitor safety and efficacy.
Farxiga (Dapagliflozin) Is Not Injected: How This Oral SGLT2 Inhibitor Actually Works
Dapagliflozin (Farxiga) is an oral tablet, not an injection. Learn how this SGLT2 inhibitor works, proper dosing technique, and why it's prescribed for type 2 diabetes, heart failure, and chronic kidney disease.
Farxiga (Dapagliflozin) Manufacturing, Supply Chain & Shortage History
A review of how Farxiga (dapagliflozin) is manufactured, AstraZeneca's supply chain structure, FDA shortage-listing status, and the pharmacology behind this SGLT2 inhibitor, with notes on where claims need primary-source verification.
Farxiga (Dapagliflozin) Missed-Dose Protocol: What to Do and When to Skip
Evidence-based guide to handling a missed dose of Farxiga (dapagliflozin). Covers timing rules, pharmacokinetics, clinical context for type 2 diabetes, heart failure, and CKD indications, plus what requires a call to your prescriber.
Farxiga (Dapagliflozin) Monitoring for Adults 30, 49: Lab Schedule, Safety Checks, and What to Track
Evidence-based monitoring guide for adults aged 30 to 49 taking dapagliflozin (Farxiga), covering renal function, ketone awareness, genital infection screening, volume status, and lab timing.
Farxiga (Dapagliflozin) Monitoring for Older Adults (50 to 64): Lab Schedule, Safety Checks, and Clinical Guidance
Evidence-based monitoring guide for dapagliflozin (Farxiga) in adults aged 50 to 64, covering renal function, ketone awareness, volume status, and lab schedules drawn from DAPA-HF and ADA/KDIGO guidelines.
Farxiga (Dapagliflozin) Monitoring for Young Adults (18 to 29): Lab Schedule, Safety Checks, and What to Track
A guide to monitoring dapagliflozin (Farxiga) in young adults aged 18 to 29, covering baseline labs, follow-up intervals, fertility considerations, and red-flag symptoms.
Farxiga (Dapagliflozin) Monitoring in Adolescents Aged 12, 17: Lab Schedule, Growth Tracking, and Safety Checks
Evidence-based monitoring protocol for dapagliflozin (Farxiga) in adolescents aged 12 to 17, covering renal labs, DKA surveillance, growth velocity, infection screening, and mental-health check-ins.
Farxiga (Dapagliflozin) Off-Label Uses with Evidence Levels
A clinician-grade review of dapagliflozin (Farxiga) off-label uses, ranked by evidence level. Covers obesity, MASLD, type 1 diabetes, polycystic kidney disease, gout, and more, with trial data and guideline citations.
Farxiga (Dapagliflozin) Overdose and Accidental Excess Dose: Clinical Management Guide
Evidence-based guide to dapagliflozin (Farxiga) overdose management, covering pharmacokinetics, clinical presentation, treatment protocols, and prevention of accidental excess dosing.
Farxiga (Dapagliflozin) Pediatric Monitoring for Children Under 12
Evidence-based monitoring guide for dapagliflozin (Farxiga) use in children under 12, covering off-label considerations, lab parameters, growth tracking, and safety signals clinicians should watch for.
Farxiga (Dapagliflozin) Real-World Evidence: Registry Data, RWE Studies, and Clinical Outcomes Beyond Trials
A physician-level review of dapagliflozin (Farxiga) real-world evidence from registries and observational studies spanning heart failure, CKD, and type 2 diabetes, with cited outcomes data from CVD-REAL, DECLARE, and DAPA-HF.
Farxiga (Dapagliflozin) Safety for Adults Aged 30 to 49
Evidence-based safety profile of dapagliflozin (Farxiga) in adults aged 30 to 49, covering side effects, monitoring, genital infections, DKA risk, and real-world clinical guidance.
Farxiga (Dapagliflozin) Safety in Older Adults 65 and Over
Evidence-based guide to dapagliflozin (Farxiga) safety in geriatric patients 65+, covering renal considerations, hypotension risk, fracture data, drug interactions, and deprescribing strategies.
Farxiga (Dapagliflozin) Safety in Older Adults Aged 50, 64
Evidence-based safety profile of dapagliflozin (Farxiga) in adults aged 50-64, covering cardiovascular benefits, renal protection, genital infections, volume depletion, and DKA risk with clinical trial data.
Farxiga (Dapagliflozin) Safety in Young Adults (18 to 29): What the Evidence Shows
A clinical review of dapagliflozin (Farxiga) safety data specific to young adults aged 18 to 29, covering side effects, fertility considerations, and monitoring recommendations.
Farxiga Adolescent (12 to 17) Safety: What Patients and Parents Need to Know
A guide to dapagliflozin (Farxiga) safety in adolescents aged 12 to 17, covering FDA approval history, the state of pediatric evidence, diabetic ketoacidosis risk, growth monitoring, and dosing guidance.
Farxiga Cost in Arkansas 2026: Cash Price, Medicaid, Compounded Options
A complete 2026 guide to dapagliflozin (Farxiga) pricing in Arkansas, including Medicaid prior authorization rules, AstraZeneca savings programs, compounded dapagliflozin legality via 503A pharmacies, and telehealth access.
Farxiga Cost in Iowa 2026: Cash Price, Medicaid Coverage & Savings Options
Farxiga (dapagliflozin) costs $620/month cash in Iowa in 2026. Iowa Medicaid does not cover it. Learn how AstraZeneca savings cards, GoodRx, and compounded dapagliflozin via 503A pharmacies can cut your out-of-pocket cost.
Farxiga Cost in Kansas 2026: Price, Insurance, Medicaid, and Compounding Options
Find out what Farxiga (dapagliflozin) costs in Kansas in 2026, whether Kansas Medicaid covers it, how the AstraZeneca savings card works, and whether compounded dapagliflozin is a legal alternative.
Farxiga Cost in Mississippi 2026: Cash Price, Medicaid, and Compounded Options
Find out exactly what Farxiga (dapagliflozin) costs in Mississippi in 2026, whether Mississippi Medicaid covers it, how the AstraZeneca savings card works, and whether compounded dapagliflozin is a legal alternative.
Farxiga Cost in Nevada 2026: Cash Price, Insurance, Medicaid, and Compounded Options
A 2026 guide to Farxiga (dapagliflozin) cost in Nevada, covering cash price ranges, Nevada Medicaid status, commercial insurance patterns, AstraZeneca savings programs, and the legal status of compounded dapagliflozin from 503A pharmacies, with guidance on what to verify before you rely on any specific number.
Showing the first 60 matches. Use search or filters to narrow the library.